Disclosure of Compensation Related Costs, Share-based Payments [Text Block] | 9 . SHARE-BASED COMPENSATION The Company accounts for share-based payment arrangements using fair value. If an award vests or becomes exercisable based on the achievement of a condition other than service, such as for meeting certain performance or market conditions, the award is classified as a liability. Liability-classified awards are remeasured to fair value at each balance sheet date until the award is settled. The Company currently has no liability-classified awards. Equity-classified awards, including grants of employee stock options, are measured at the grant-date fair value of the award and are not subsequently remeasured unless an award is modified. The cost of equity-classified awards is recognized in the statement of operations over the period during which an employee is required to provide the service in exchange for the award, or the vesting period. All of the Company’s stock options are service-based awards, and because the Company’s stock options are “plain vanilla,” as defined by the U.S. Securities and Exchange Commission in Staff Accounting Bulletin No. 107, they are reflected only in equity and compensation expense accounts. Stock Options As of September 30, 2016, the Company had two equity-based compensation plans: the 2016 Cyanotech Equity Incentive Plan (the “2016 Plan”) and the 2014 Independent Director Stock Option and Restricted Stock Grant Plan (the “2014 Directors Plan”). The Company has also issued stock options, which remain outstanding as of September 30, 2016, under two equity-based compensation plans which have expired according to their terms: the 2005 Stock Option Plan (the “2005 Plan”) and the 2004 Independent Director Stock Option and Stock Grant Plan (the “2004 Directors Plan”). These plans allowed the Company to award stock options and shares of restricted common stock to eligible employees, certain outside consultants and independent directors. On August 25, 2016, the Company’s shareholders approved the 2016 Plan as a successor to the 2005 Plan, authorizing the Board of Directors to provide incentive to the Company’s officers, employees and certain independent consultants through equity based compensation in the form of stock options, restricted stock, restricted stock units, stock appreciation rights and other stock based awards (together, “Stock Awards”) and performance shares and performance units (together “Performance Awards”). Awards under the 2016 Plan are limited to the authorized amount of 1,300,000 shares, up to 600,000 of which are available for issuance in connection with Performance Awards and Stock Awards. As of September 30, 2016, there were 1,300,000 shares available for grant under the 2016 Plan. On August 28, 2014, the Company’s shareholders approved the 2014 Directors Plan authorizing the Board of Directors to provide incentive to the Company’s independent directors through equity based compensation in the form of stock options and restricted stock. Awards under the 2014 Directors Plan are limited to the authorized amount of 350,000 shares. As of September 30, 2016, there were 289,124 shares available for grant under the 2014 Directors Plan. The 2005 Plan and the 2004 Directors Plan have expired, and therefore no additional awards will be issued under those plans. The following table presents shares authorized, available for future grant and outstanding under each of the Company’s plans: As of September 3 0 , 201 6 Authorized Available Outstanding 2016 Plan 1,300,000 1,300,000 — 2014 Plan 350,000 289,124 12,000 2005 Plan — — 642,500 2004 Directors Plan — — 12,000 Total 1,650,000 1,589,124 666,500 All stock option grants made under equity-based compensation plans were issued at exercise prices no less than the Company’s closing stock price on the date of grant. Options under the 2005 Plan and 2014 Directors Plan were determined by the Board of Directors or the Stock Option and Compensation Committee of the Board in accordance with the provisions of the respective plans. The terms of each option grant include vesting, exercise, and other conditions are set forth in a Stock Option Agreement evidencing each grant. No option can have a life in excess of ten (10) years. The Company records compensation expense for employee stock options based on the estimated fair value of the options on the date of grant using the Black-Scholes option-pricing model. The model requires various assumptions, including a risk-free interest rate, the expected term of the options, the expected stock price volatility over the expected term of the options and the expected dividend yield. Compensation expense for employee stock options is recognized ratably over the vesting term. Compensation expense recognized for options issued under the 2005 Plan was $58,000 and $136,000 for the three and six months ended September 30, 2016, respectively. Compensation expense recognized for options issued under the 2005 Plan was $161,000 and $324,000 for the three and six months ended September 30, 2015, respectively. Compensation expense recognized for options issued under the 2014 Directors Plan was $1,000 and $1,500 for the three and six months ended September 30, 2016. Compensation expense recognized for restricted stock issued under the 2014 Directors Plan was $78,000 for the three and six months ended September 30, 2016. No compensation expense was recognized under the 2014 Directors Plan for the three and six months ended September 30, 2015. All share-based compensation has been classified as general and administrative expense in the consolidated statement of operations. A summary of option activity under the Company’s stock plans for the six months ended September 30, 2016 is presented below: Option Activity Shares Weighted Price Weighted Average years) Aggregate Outstanding at March 31, 2016 685,000 $ 4.65 5.7 $ 566,323 Granted 6,000 $ 4.08 Exercised (1,500 ) $ 3.11 Forfeited (23,000 ) $ 5.02 Outstanding at September 30, 2016 666,500 $ 4.63 5.2 $ 136,596 Exercisable at September 30, 2016 578,000 $ 4.41 5.0 $ 136,596 The aggregate intrinsic value in the table above is before applicable income taxes and represents the excess amount over the exercise price optionees would have received if all options had been exercised on the last business day of the period indicated, based on the Company’s closing stock price of $3.69 for such day. A summary of the Company’s non-vested options for the six months ended September 30, 2016 is presented below: Nonvested Options Shares Weighted Nonvested at March 31, 2016 171,250 $ 3.75 Granted 6,000 .83 Vested (83,750 ) 3.29 Forfeited (5,000 ) 3.48 Nonvested at September 30, 2016 88,500 $ 4.00 The following table summarizes the weighted average characteristics of outstanding stock options as of September 30, 2016: Outstanding Options Exercisable Options Range of Number Remaining Weighted Price Number of Weighted Price $1.60 - $3.70 146,920 3.5 $ 2.76 146,920 $ 2.76 $3.71 - $4.42 200,580 5.0 $ 3.82 194,580 $ 3.82 $4.43 - $5.40 95,000 6.7 $ 5.00 66,500 $ 5.01 $5.41 - $7.08 224,000 5.9 $ 6.42 170,000 $ 6.26 Total stock options 666,500 5.2 $ 4.64 578,000 $ 4.41 The range of fair value assumptions related to options granted during the six months ended September 30, 2016 were as follows: 201 6 Exercise Price $ 4.08 Volatility 51.13 % Risk Free Rate 0.60 % Vesting Period (years) 0.5 Forfeiture Rate 0.00 % Expected Life (in years) 1.00 Dividend Rate 0 % As of September 30, 2016, total unrecognized stock-based compensation expense related to all unvested stock options was $245,000, which is expected to be expensed over a weighted average period of 2.2 years. |